Cargando…
Crosstalk between Mesenchymal Stem Cells and Cancer Stem Cells Reveals a Novel Stemness-Related Signature to Predict Prognosis and Immunotherapy Responses for Bladder Cancer Patients
Mesenchymal stem cells (MSCs) and cancer stem cells (CSCs) maintain bladder cancer (BCa) stemness and facilitate the progression, metastasis, drug resistance, and prognosis. Therefore, we aimed to decipher the communication networks, develop a stemness-related signature (Stem. Sig.), and identify a...
Autores principales: | Ma, Lin, Chen, Hualin, Yang, Wenjie, Ji, Zhigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003512/ https://www.ncbi.nlm.nih.gov/pubmed/36902193 http://dx.doi.org/10.3390/ijms24054760 |
Ejemplares similares
-
Machine learning-based identification of tumor-infiltrating immune cell-associated model with appealing implications in improving prognosis and immunotherapy response in bladder cancer patients
por: Chen, Hualin, et al.
Publicado: (2023) -
Tumor stemness score to estimate epithelial-to-mesenchymal transition (EMT) and cancer stem cells (CSCs) characterization and to predict the prognosis and immunotherapy response in bladder urothelial carcinoma
por: Zhang, Yanlong, et al.
Publicado: (2023) -
Gene signature related to cancer stem cells and fibroblasts of stem‐like gastric cancer predicts immunotherapy response
por: Sung, Ji‐Yong, et al.
Publicado: (2023) -
PPAR-γ Signaling Crosstalk in Mesenchymal Stem Cells
por: Takada, Ichiro, et al.
Publicado: (2010) -
Stemness Signature of Equine Marrow-derived Mesenchymal Stem Cells
por: Zahedi, Morteza, et al.
Publicado: (2017)